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1. Introduction 
The increase in contractility which occurs on 
exposure of cardiac muscle to catecholamines is 
thought to be mediated by an increase in the intracel- 
lular concentration of cyclic 3’,5-AMP [ 1,2]. It is 
proposed that this increase activates cyclic 3’,5’-AMP- 
dependent protein kinase, resulting in the phosphory- 
lation of membrane and myofibrillar proteins 
(reviewed in [3,4]). The phosphorylation of a num- 
ber of cardiac myofibrillar proteins has been studied 
in detail both in vitro and in vivo. The inhibitory sub- 
unit of troponin (troponin-I) can be phosphorylated 
in vitro by cyclic AMP-dependent protein kinase 
[S ,6], and in perfused heart in response to agents 
which elevate cyclic 3’,5’-AMP [7,8]. This results in 
a decrease in calcium sensitivity of both the adeno- 
sine triphosphatase of isolated myofibrils [9,10] and 
tension development in skinned cardiac fibres [ 11 ,121. 
It is possible that this is related to the decrease in 
relaxation time observed on treatment of cardiac 
muscle with catecholamines [3,4]. The P-light chain 
of myosin is also phosphorylated in cardiac muscle, 
although the light chain kinase is a Ca’+-dependent 
enzyme and is not activated by cyclic AMP [ 13,141. 
The level of phosphorylation of the P-light chain in 
perfused hearts does not appear to be affected by 
catecholamines or increased Ca*+ however [ 15 ,161, 
and is probably not involved with short-term regula- 
tion of contractility. 
C-protein is a protein of& 140 000-150 000 
which is associated with myosin in the thick filaments 
of striated muscle [17,18]. Use of antibodies to 
C-protein on intact myofibrils showed that it was 
located at a spacing of 43 nm along the thick filament 
[ 191. C-protein will bind to various fragments from 
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the tail region of myosin [20], and may possibly be 
concerned with either the structural integrity or the 
assembly of the thick filament [ 18,211. Recently it 
has been shown that at physiological ionic strength 
C-protein from rabbit skeletal muscle caused a mild 
activation of actin-activated myosin ATPase [22]. 
However, the precise function of C-protein is at 
present still unknown. 
When cardiac myofibrils were incubated with 
cyclic AMP-dependent protein kinase and [T-~‘P]ATP, 
significant incorporation of 32P occurred in only 2 
proteins [9]. One of these was troponin-I, the other 
hadM, -150 000. Here we show that in rat hearts 
perfused with 32Pi, a protein of Mr 1.50 000 was phos- 
phorylated, and that this phosphorylation was 
increased 5-6-fold by exposure of the hearts to 
adrenaline for 20 s. Evidence is presented suggesting 
that this phosphorylated protein is C-protein. 
2. Methods 
2.1. Phosphorylation of proteins in perfused heart 
Hearts from female Wistar rats (200-220 g) were 
perfused by the Langendorff technique with 32Pi for 
15 min (spec. radioact. 2 Bq/pmol) as in [7,16]. 
Hearts were then perfused with 5 FM adrenaline for 
up to 60 s before being freeze-clamped and powdered 
at -196°C. 
Samples for polyacrylamide gel electrophoresis 
were prepared essentially as in [23]. Frozen tissue 
(200 mg) was homogenised in 2 ml 8 M urea, 100 mM 
glycine, 5 mM EDTA,O.l mM phenylmethylsulphonyl 
fluoride (PMSF) (pH 1.5). Insoluble protein was 
removed; the solubilised protein precipitated with 
trichloracetic acid and dissolved in buffer for electro- 
129 
Volume 122, number I FEBS LETTERS December 1980 
phoresis on polyacrylamide by the Laemmli method 
[24]. After electrophoresis, protein was detected with 
Coomassie brilliant blue and protein-bound 32P mea- 
sured by densitometric scanning after autoradiography 
of the gel. The autoradiographs were within the range 
of proportionality between absorbance and radio- 
activity. 
The specific radioactivity of [y-32P]ATP in frozen 
hearts was measured as in [25]. 
2.2. Preparation of 150 000 M, protein 
This was prepared by a modification.of the meth- 
od in [ 181. Following perfusion with 32PI as above, 
two rat hearts (unfrozen) were finely chopped and 
homogenised by hand in 12 ml 50 mM KP,) 70 mM 
NaF, 5 mM EDTA, 0.3 M sucrose, 0.1 mM PMSF (pH 
7.0) and a crude myofibrillar preparation made by 
washing in 1% Triton X-100 [ 151. All extraction pro- 
cedures were carried out at 0-4’C. The myofibrils 
were extracted in 7.5 ml 0.15 M Kpi, 10 mM EDTA 
(pH 7.0) for 15 min, and the solubilised protein 
dialysed overnight against 0.15 M Kpi, 1 mM EDTA, 
2 M urea (pH 7.5). The protein was chromatographed 
on a column (5 cm X 1 cm) of DEAE-Sepharose 
CLdB (Pharmacia). Protein fractions were analysed 
by polyacrylamide gel electrophoresis and autoradiog- 
raphy. 
3. Results and discussion 
3.1. Phosphorylation of the 150 000 M, protein in 
perfused heart 
Fig.1 shows the distribution of 32P in proteins 
after perfusion of hearts with 32Pi. Three major 
phosphorylated bands ofMr 150 000,27 000 and 
19 000 can be identified. The 27 000 M, protein 
co-migrated with purified troponin-I, and the 19 000 
Mr protein with the P-light chain of myosin. In con- 
trol perfusions only tbc: P-light chain contained an 
appreciable amount of ‘*P which was unchanged after 
exposure of the hearts to adrenaline [ 161. Both 
troponin-I and the 150 000 M, protein contained 
small amounts of 32P in control perfusions, which 
increased considerably on exposure to adrenaline. 
Fig.2 show the time courses of increases in aortic 
pressure and phosphorylation of the 150 000 M, pro- 
tein and troponin-I following perfusion with 5 PM 
adrenaline. There was an -5-6-fold increase in 32P 
content of the 150 000 M, protein during 22 s per- 
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Fig.1. Distribution of protein and 3*P in rat heart after per- 
fusion with 32Pi. Whole heart extracts were prepared as in 
section 2 and subjected to electrophoresis [ 241 on a 6-12.570 
gradient of polyacrylamide. 
fusion with adrenaline, which was in parallel with the 
increase in contraction. The 32P content of troponin-I 
also increased 5-6-fold over the same time-course, a 
result in agreement with earlier studies [26]. After 22 
set of exposure to adrenaline approximately equal 
amounts of 32P had been incorporated into troponin-I 
and the 150 000 Mr protein. 
3.2. Identity of the 150 000 M, protein 
The 150 000 Mr protein remained attached to rat 
heart myofibrils during extensive washing with Triton 
X-100 and low ionic strength buffers. A preparation 
of crude myosin made by extracting a rat heart 
homogenate with Cuba-Straub solution [27], also 
contained the 150 000 Mr protein, indicating a close 
association between these proteins. C-protein of 
skeletal muscle is myofibrillar, and is also extracted 
along with myosin under the above conditions [ 181. 
In order to show that the 150 000 Mr protein 
could be C-protein, further purification was carried 
out using a method for the preparation of C-protein 
from skeletal muscle [ 181. An extract of myofibrils 
was prepared and chromatographed on DEAE- 
Sepharose as in section 2. Fig.3 shows the protein 
elution patterns for extracts from both rat cardiac 
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Fig.2. Time courses of changes in aortic pressure (u) and 
phosphorylation of the 150 OOOMr protein (0) and troponin-I 
(w) following perfusion with 5 PM adrenaline. The “P incor- 
poration into the proteins was corrected by the measured 
[$*P]ATP specific radioactivity of each heart, and is 
expressed relative to the ‘*P incorporation in the 150 000 
Mr protein in perfusions without adrenaline. 
and skeletal muscle. There was a small peak of 
unbound protein, and a large peak which eluted with 
0.5 M KCl. When the two protein peaks from cardiac 
muscle were analysed by polyacrylamide gel electro- 
phoresis, peak I was enriched in the I50 000 Mr pro- 
tein, but also contained some myosin and thin fila- 
ment proteins (fig.4). Peak II contained very little 
of the 150 000 Mr protein, and was mainly undissoci- 
ated actomyosin. Peak I from rat skeletal muscle con- 
tained predominantIy a protein of Mr 140 000 (not 
shown), which is identical to the elution pattern 
observed with C-protein from rabbit skeletal muscle 
[IS]. The majority of 32P in peak I prepared from 
hearts perfused with 32P. and adrenaline migrated in 
the same place as the pr&ein of AZ,. 150 000 (fig.4). 
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Fig.3. Separation of 150 000 Mr protein by chromato~aphy 
on DEAE-Sepharose. Cardiac (-_) or skeletal (- --) 
myofibrils were extracted and chromatographed as in section 
2. The arrow indicates the addition of 0.5 M KC1 to the 
elution buffer. 
We therefore tentatively identify the protein of Mr 
150 000 as C-protein. Peak I also contained other 
phosphorylated proteins, the major one being tro- 
ponin-I. Several of the others appear to be proteolytic 
fragments of C-protein, as aged preparations show a 
decrease of 32P-labelIed protein of Mr 150 000, and 
an increase of 32P in the lower Air proteins. 
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Fig.4. Distribution of protein (I) and 32P(II) in fractions from 
stages during the preparation of the 150 000 Mr protein: (A} 
crude myofibrillar fraction; (B) extract of myoftbrils in 
0.15 M KPi, 10 mM EDTA (pH 7.0); (C) peak I from the 
DEAE-Sepharose chromatography. 
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It appears from these results that C-protein in 
heart has a higher Mr than in skeletal muscle. In addi- 
tion, cardiac C-protein dissociates less easily from 
other myofibrillar proteins than C-protein from 
skeletal muscle, and is thus more difficult to purify. 
3.3. General discussion 
Previous results [9] showed that a protein of Mr 
150 000 could be phosphorylated in myofibrils from 
beef and rat heart by cyclic AMP-dependent protein 
kinase. Here we show that this protein is probably 
C-protein and is phosphorylated in intact heart in 
response to adrenaline over the same time course as 
troponin-I.Troponin-I is known to be phosphorylated 
in vivo by cyclic AMP-dependent protein kinase [28]. 
These results suggest hat C-protein is also phospho- 
rylated in vivo by the same kinase. 
After stimulation of hearts with adrenaline the 
amount of 32P in C-protein was very similar to that 
in troponin-I (fig.2). It is possible to calculate the 
molar ratio of 32P to C-protein in these hearts if it is 
assumed that the ratio of troponin to C-protein is the 
same in heart as in skeletal muscle. In skeletal muscle 
the ratio of troponin: C-protein is -5 : 1 (G. Offer, 
personal communication). After 20 s perfusion of rat 
heart with adrenaline, troponin-I contains 1 mol 
32P/mol [26]. From these assumptions and the results 
of fig.2 it appears that in control conditions C-protein 
contains - 1 mol 32P/mol, and that this increases to 5 
mol/mol with adrenaline. This is obviously a pre- 
liminary calculation, and requires verification by 
direct measurement of covalentlybound phosphate in 
purified C-protein. Work is also in progress to confirm 
that this 150 000 Mr protein is cardiac C-protein. 
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